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of CCL3 and CCL4 were over 21ng/L in normal adults, which were much
higher than IL-6 and IL-1b (Figure 2B). The concentration of CCL3 was
36.34±2.68ng/l, 55.30±4.05ng/l, and 62.56±2.39ng/l in normal adults,
medial OA patients, and severe OA patients (Figure 2B). The ratio of
CCL4 was signiﬁcant different in normal adults and different stages
of OA patients (Figure 1), and the concentration was 21.75±4.80ng/l,
43.80±4.27ng/l, and 60.50±5.87ng/l (Figure 2B).
Conclusion: CCL3, CCL4, CXCL2, IL-8 and IL-1b could be serum
biomarkers to identify healthy adults, early stage OA patients and late
stage OA patients from our primary data, especially CCL4 and CXCL2
were detectable and useful.
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FIBULIN-3 FRAGMENTS (FIB3–1 AND FIB3–2) ARE POTENTIAL NEW
BIOMARKERS FOR THE DIAGNOSIS OF OSTEOARTHRITIS
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Luc, Bruxelles, Belgium
Purpose: Fibulin-3 is a member of the ﬁbulin family protein, newly
recognized as extracellular matrix protein that negatively regulates
chondrocyte differentiation. Using tandem mass spectrometry, we have
found elevated levels of two fragments of ﬁbulin-3 (Fib3–1 and Fib3–2)
in the urine OA patients compared to those of healthy or osteoporotic
subjects. The aim of this study was to measure Fib3–1 and Fib3–2 in
serum of healthy subjects and osteoarthritic (OA) patients using two
speciﬁc immunoassays.
Methods: Sera were collected from 236 healthy ambulatory subjects
(93 women, 143 men) aged from 20 to 64 years (mean ± SD: 43.8±11.7)
and attending a blood donor center and from 39 patients aged from 39
to 82 years (mean ± SD: 68.4±11.1) with knee OA (29 women, 10 men)
diagnosed according to the ACR clinical and radiological criteria. None
of the healthy subjects had histories of OA or current OA symptoms
and none of them were subjected to joint radiography or other imaging
assessment. Two rabbit antisera, AS88 and AS94, with a high speciﬁcity
for Fib3–1 and Fib3–2, respectively were produced and used to develop
speciﬁc immunoassays. The lower detection limit of the assays was
5.2 pM for Fib3–1 and 8 pM for Fib3–2 and the working range of
concentration was comprised between 12.5 pM and 400 pM. Antisera
did not recognize native ﬁbuline-3 and did not cross-react with each
fragment.
Results: Immunostaining revealed the extensive presence of Fib3–1 and
Fib3–2 in the chondrocytes and extracellular matrix of the superﬁcial
layer of the ﬁbrillated cartilage. The median concentrations of Fib3–1 and
Fib3–2 in sera of healthy subjects were 58.5 pM (25%-75% range 46.2–
73.9 pM) and 140.8 pM (25%-75% range 126.5–156.3 pM), respectively.
Fib3–1, but not Fib3–2, was confounded by age and gender. By
comparison with age-matched healthy subjects, Fib3–1 (median, 54.6
pM vs 71.1 pM; p < 0.01) and Fib3–2 (median, 144.4 pM vs 183.0 pM;
p < 0.0001) serum levels were elevated in OA patients. No correlation was
found between Fib3–1 and Fib3–2 serum levels, suggesting that these
biomarkers reﬂect different aspects of the disease.
Conclusions: By comparison with healthy subjects, Fib3–1 and FiB3–2
serum levels are found elevated in patients with knee OA. Furthermore,
the immunohistochemical ﬁndings indicate that ﬁbrillated cartilage is a
major source of ﬁbulin-3 fragments. Fib3–1 and Fib3–2 are considered
as promising biochemical markers for the diagnosis of OA.
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Purpose: Magnetic resonance imaging (MRI) has helped experts to
diagnose Osteoarthritis (OA) by detecting early tissue changes. Current
semi quantitative measures of the whole knee joint cover various
structures within the joint, for example, the whole-organ MRI score
(WORMS), the Knee Osteoarthritis Scoring System (KOSS) and the Boston-
Leeds Osteoarthritis Knee Score (BLOKS). Focusing on bone quality, to
the authors’ knowledge, only semi-automatic quantitative method exists
for quantifying knee trabecular structure in MRI. We investigated the
possibility of detecting OA by a fully automatic method analyzing the
trabecular structure of the tibia bone.
Methods: The data consisted of 313 knee MRI from a community-based,
non-treatment study with 159 subjects. The population characteristics
were: age 56±16, Body Mass Index 26±4, 47% female, and 19% with
radiographic OA (Kellgren Lawrence grade, KLG > 1). The KLG was
determined from load-bearing radiographs in semi-ﬂexed position using
the SynaFlex (Synarc). MRI scans were acquired using a Turbo 3D T1
sequence from a 0.18T Esaote scanner (40° FA, TR 50ms, TE 16ms, scan
time 10 minutes, resolution 0.7mm×0.7mm×0.8mm).
To quantify the bone structure, initially a voxel classiﬁcation method
determines a region-of-interest (ROI) by segmenting the tibia bone and
from there extracting the trabecular bone. Figure 1 shows the segmented
tibia bone in light gray and the ROI in light green. From the ROI, a generic
set of 534 features is extracted by applying Gaussian derivatives at
multiple scales. The process captures the differential geometry structure
of the local intensities, allowing analyze the intricate network of the
trabecular bone anatomy.
At next step, a machine learning approach applies partial least squares
feature extraction to identify the linear combination of the features that
best discriminate the disease. The features extracted are employed to
train the linear classiﬁer to recognize the trabecular bone of a knee with
OA. Using cross-validation, the bone structure marker estimates for each
knee the classiﬁed probability of having OA.
Fig. 1.
Results: The resulting marker was analyzed for the ability to separate
OA (KLG > 1) and healthy knees. The median area under the receiver-
operator characteristics curve was 0.91 (p < 0.0001). Figure 2 shows the
cross-sectional separation.
Fig. 2.
Conclusions: The investigation revealed that disease-related bone
structure characteristics were reﬂected in the low-ﬁeld MRI appearance.
The applied texture analysis captured tissue changes and provided
insights into OA diagnosis. Even though the individual trabeculae are not
visible, the outcome of our investigation demonstrated the possibility
of analyzing the intricate network of the trabecular bone as a whole
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and from this automatically to quantify a bone structure marker strongly
associated with the presence of OA. The advantages of this approach are
the use of low cost MRI equipments and a fully automatic computer-
based framework, which makes the developed marker well suitable for
large longitudinal clinical studies.
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QUANTITATIVE AND HISTOPATHOLOGICAL ANALYSIS OF
OSTEO-ARTHRITIC CARTILAGE USING MRI, HRMAS SPECTROSCOPY
AND IMMUNO-HISTOCHEMISTRY
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A. Horvai, X. Li. Univ. of California, San Franscisco, San Francisco, CA, USA
Purpose: Osteoarthritis (OA) involves cartilage degradation resulting
from biochemical changes. In this study we perform ex-vivo T1-rho
weighted MRI followed by high resolution magic angle spinning (HRMAS)
NMR spectroscopy at 11.7 T using knee articular cartilage acquired from
OA patients during total knee replacement (TKA) surgery. HRMAS ensures
tissue integrity and allows immuno-histochemistry (IHC) and histology
of the same cartilage samples following spectroscopy. We use immuno-
histochemistry and histology to show that the biochemical changes
measured with HRMAS correlate with the histopathology of cartilage,
and thus validate that HRMAS is a viable and powerful addition to our
capabilities to study early and late OA, and it complements the T1-
rho relaxation map acquired using ex-vivo MRI that depicts regions of
increased cartilage degradation in OA specimens.
Methods: Osteoarthritic samples were excised from OA patients (n = 4,
range = 57–81 years) undergoing TKA during surgery. In case of each
patient lateral and medial femoral condyles were acquired, ﬂash-frozen
in dry ice, then immediately stored at −80C until experiments. The
condyles were mounted and secured on a grid (Fig. 1) after thawing
to obtain T1-rho MRI of the ex-vivo specimens using a 3 Tesla GE
scanner. Semi-automatic segmentation software developed in-house
was used to segment the cartilage overlying the condyles and the
mean+SD of T1rho was determined in each case. 8 cartilage punches
were acquired per patient using a 3mm punch resulting in a total of
n = 24 punches. The samples were then analyzed using HRMAS NMR
spectroscopy using a Carr Purcell Meiboom Gill (CPMG) pulse sequence
to determine the biochemical composition of the samples. Following
HRMAS, histologic (hematoxylin/eosin and Safranin-O/Fast Green) and
immunohistochemical evaluation were performed on the same samples
using antibodies that recognize aggrecan cleavage neoepitopes G1-
NITEGE (reﬂecting activities of ADAMTS) and G1-VDIPEN (reﬂecting
activities of MMPs) as well as those that recognize the collagen-II
cleavage neoepitopes (GPQG).
Fig. 1. OA knee cartilage/bone specimen ﬁxed on a plastic grid for MRI
ex-vivo scan.
Results: Figure 2(A) shows a representative segmented ex-vivo T1-rho
weighted MRI color map of the lateral inferior femoral condyle of an OA
patient. The mean+ SD of T1-rho for the segmented cartilage was (60.4+
18.45) ms. The corresponding HRMAS spectra of the punch sample shown
in 2(A) is indicated in Figure 2(B), with well resolved spectral peaks
including N-acetyl (reﬂecting proteoglycan concentration) and alanine
(reﬂecting collagen concentration). Figure 3 shows the H&E staining,
Safranin-O staining and the immuno-histochemical labeling of anti-
NITEGE of the same punch sample as was used for HRMAS acquisition.
Conclusions: This study is a multi-modality approach to understand the
biochemical changes involved in OA. The use of HRMAS spectroscopy
after performing ex-vivo T1-rho MRI allows the correlation of T1-
rho relaxation with biochemical proﬁles of cartilage as determined
by HRMAS. The fact that cartilage samples remain intact after HRMAS
provides the ability to perform histo-pathological analysis of the same
cartilage samples. Quantitative analysis of T1-rho values, HRMAS spectral
quantiﬁcation and histology/IHC staining grading will be performed with
data collected from this study. This technique provides a validation of
spectroscopy approach and helps establish potential biomarkers of the
cartilage degradation process in OA.
Fig. 2. (A) Representative ex-vivo T1-rho weighted MRI of osteoarthritic
femoral condyle and (B) the corresponding HRMAS spectra of a cartilage
punch (indicated in A) acquired from the same femoral condyle
indicating the resonance arising from the N-acetyl side-chain protons of
proteoglycan and the alanine resonance corresponding to the collagen.
Fig. 3. Histological/immunohistochemical sections of cartilage (the same
punch sample as in Figure 2) stained using (A) H&E, (B) Safranin-O,
(C) anti-NITEGE.
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COLLAGEN BIOMARKER RESPONSE TO ACUTE JOINT INJURY IN A
NON-TERMINAL ANIMAL MODEL OF OSTEOARTHRITIS
M. Boyce1, T.N. Trumble1, D.M. Groschen1, K.A. Merritt2, M.P. Brown2.
1Univ. of Minnesota, St. Paul, MN, USA; 2Univ. of Florida, Gainesville, FL,
USA
Purpose: Biomarkers of cartilage metabolism have potential to identify
early stages of osteoarthritis (OA), before clinical evidence is present,
and thus facilitate early diagnosis and therapy. The purpose of this study
was to identify synovial ﬂuid (SF) and serum biomarker changes that
occur after acute joint injury using an equine model of early OA. We
hypothesized that collagen biomarkers would identify early metabolic
changes that occur secondary to acute osteochondral (OC) injury.
Methods: Twenty-two clinically and radiographically normal age- and
sex-matched Quarter Horses were randomly divided into 2 groups:
(1) horses (n =11) that had an OC fragment created arthroscopically
on the dorsomedial aspect of the ﬁrst phalanx in one randomly
selected metacarpophalangeal (MCP) joint and a sham operation in the
contralateral joint at week 0; and (2) unoperated exercise control horses
(n = 11). All horses were exercised on a high-speed treadmill 5 days/week
from week 2 to week 16. Blood was collected from the jugular vein and SF
samples were collected without lavage from both MCP joints of all horses
at baseline (week 0), week 2, 8, and 16. Commercially available collagen
degradation (CTXII [IDS/Nordic], C2C, C12C [IBEX]) and synthesis (CPII
[IBEX]) ELISA assays were used to analyze SF and serum samples. All
assays were previously validated for equine use. Data was assessed for
normality and outliers were removed from further analyses. A repeated
measures ANOVA with a Tukey’s test for multiple comparisons was used
for all analyses. P≤ 0.05 was considered signiﬁcant. All procedures were
approved by institutional animal care and use committees.
